Q4 2019 · —
Revenue—
Net Income-$11.68K-$11.68K no prior Q4 2018 on fileN/M vs Q3 2019
EPS Diluted$0.00$0.00 no prior Q4 2018 on fileN/M vs Q3 2019
Operating Income-$10,238—
Operating Cash Flowderived-$5,591,000—
Free Cash Flowderived-$5,776,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q4 2018 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR